Insert text and press Enter to Search

News

You searched for
Tag: Products


European Parliament vote on the revision of the EU’s legislative framework on F-gas: climate targets need innovative solutions

03/04/2023

In 2022 Chiesi Group has been confirmed as the 1st Italian pharmaceutical company for the number of patents filed

28/03/2023

What does it mean to be a B Corp? Chiesi's choice for a sustainable future

01/03/2023

Chiesi Group stands in solidarity with the people of #Turkiye and #Syria

09/02/2023

The Alphabet of Sustainability

01/02/2023

Discovering ESG Criterias (Environmental, Social and Governance), the Chiesi Group's committment

17/01/2023

Energize Programme: a shared commitment to accelerate the adoption of renewable energy in the pharmaceutical sector

17/11/2022

“Vendor Day”: the role of Chiesi Group’s Value Chain in shaping the future

16/11/2022

Chiesi recognized by Biden Administration for its support and commitment to greater resilience in the fight against climate change

14/11/2022

Fostering innovation for rare diseases in Europe: Chiesi supports the RDR Challenges Call

27/10/2022

A new EU proposal to protect people and planet by reducing F-gases

01/08/2022

Chiesi Group joins Biden Administration pledge to decarbonize healthcare sector

06/07/2022

New record for Chiesi Group: in 2021 it’s confirmed top Italian pharmaceutical company for number of patents filed

04/07/2022

The Art of Healing

08/06/2022

Dear colleagues, it's showtime!

31/05/2022